What sector does C4 Therapeutics, Inc (CCCC) operate in?
C4 Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is C4 Therapeutics, Inc (CCCC) current stock price?
As of the latest data, C4 Therapeutics, Inc stock price is $2.75, with a previous close of $2.99. C4 Therapeutics, Inc lost -$0.24 in the last trading session, representing a -8.03% loss.
What is C4 Therapeutics, Inc (CCCC) current market capitalization?
C4 Therapeutics, Inc market cap is approximately 266.51 million.
What is C4 Therapeutics, Inc (CCCC) Earnings Per Share (EPS)?
The trailing EPS is -$1.27, and the forward EPS is -$1.23.
What is C4 Therapeutics, Inc (CCCC) EBITDA?
C4 Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.94 million.
Does C4 Therapeutics, Inc (CCCC) pay dividends?
No. C4 Therapeutics, Inc does not pay a dividend.
How did C4 Therapeutics, Inc (CCCC) perform in its most recent earnings report?
In the last report (December 31, 2025), C4 Therapeutics, Inc posted an EPS surprise of 37.63% and a revenue surprise of -63.75%.
When is C4 Therapeutics, Inc (CCCC) next earnings report?
C4 Therapeutics, Inc is expected to release its next earnings report on March 31, 2026.
What is C4 Therapeutics, Inc (CCCC) beta (volatility) score?
C4 Therapeutics, Inc has a beta of 2.937, indicating very high volatility compared to the market.